Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 8 Search
2025
Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two‐Centre Open, Single‐Arm Trial
Endocrinology, Diabetes & Metabolism
2024
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Metabolism
2024
Metabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms
International Journal of Molecular Sciences
2023
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
Inflammopharmacology
2023
Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
Journal of Diabetes Research
2023
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Endocrine Reviews
2023
Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form
Frontiers in Endocrinology
2022
FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes
American Journal of Physiology-Endocrinology and Metabolism